Vyas Tungaturti is an M&A advisor with nearly two decades on the execution side of deals: first at Deloitte Consulting, then, since 2018, as an independent advisor to Big 4 firms on due diligence, integration and carve-outs across more than 50 transactions. He founded CorpDev.Org, runs CogTech, and builds Kai, AI-native due diligence for M&A and PE teams: upload a data room and within hours Kai has read every document, found every risk and opportunity, priced with evidence, and traced every figure to its source.
Deal Structure Redefines Corporate Control Paradigms The controversial 2024 restructuring of U.S. Steel (NYSE: X) created a 1% "golden share" granting former President Donald Trump veto rights over:...
BlackRock has unveiled an unprecedented $400 billion private markets fundraising target through 2030, signaling the world's largest asset manager's strategic pivot toward alternative investments....
Forward Air Corporation (NASDAQ:FWRD) has become the focal point of intense private equity interest as Blackstone, Apollo Global Management, Platinum Equity, and Clearlake Capital engage in...
Spanish banking group Banco Sabadell has initiated a strategic pivot by exploring the sale of its UK subsidiary TSB Bank, marking a critical juncture in its decade-long British expansion. This move...
Mitsubishi Corporation stands poised to make its largest-ever acquisition with a potential $8 billion purchase of Aethon Energy Management's U.S. shale gas assets, according to multiple sources...
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17,...
The acquisition of CW Advisors by Osaic represents a pivotal moment in the ongoing consolidation of the registered investment advisor (RIA) sector, combining Audax Private Equity’s operational...
Charlotte-based Bojangles has engaged investment bankers to explore a potential sale that could value the fried chicken chain at $1.5 billion – nearly triple its 2019 acquisition price – as...
The Pennsylvania House of Representatives has passed landmark legislation (House Bill 1460) imposing unprecedented oversight on private-equity healthcare transactions, marking a watershed moment in...
In a landmark consolidation of Germany's biotechnology sector, BioNTech SE (NASDAQ: BNTX) has announced its acquisition of CureVac NV (NASDAQ: CVAC) through an all-stock transaction valued at $1.25...
